SEC Info - Unitedhealth Group Inc - ‘10-Q’ for 9/30/17

SEC Info℠

Home

Help

Please Sign In

Unitedhealth Group Inc – ‘10-Q’ for 9/30/17 – ‘EX-101.SCH’

On: Tuesday, 11/7/17, at 4:13pm ET · For: 9/30/17 · Accession #: 731766-17-45 · File #: 1-10864

  As Of               Filer                 Filing    For·On·As Docs:Size

11/07/17  Unitedhealth Group Inc            10-Q        9/30/17   58:9.9M

Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    714K 
 2: EX-10.1     Material Contract                                   HTML     26K 
 3: EX-10.2     Material Contract                                   HTML     23K 
 4: EX-10.3     Material Contract                                   HTML     24K 
 5: EX-12.1     Statement re: Computation of Ratios                 HTML     29K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     33K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     22K 
14: R1          Document and Entity Information Document            HTML     37K 
15: R2          Condensed Consolidated Balance Sheets               HTML    118K 
16: R3          Condensed Consolidated Balance Sheet                HTML     34K 
                (Parenthetical)                                                  
17: R4          Condensed Consolidated Statements of Operations     HTML     87K 
18: R5          Condensed Consolidated Statements of Comprehensive  HTML     56K 
                Income                                                           
19: R6          Condensed Consolidated Statements of Changes in     HTML     87K 
                Equity                                                           
20: R7          Condensed Consolidated Statements of Cash Flows     HTML    105K 
21: R8          Basis of Presentation (Notes)                       HTML     34K 
22: R9          Investments (Notes)                                 HTML    222K 
23: R10         Fair Value (Notes)                                  HTML    182K 
24: R11         Other Current Receivables (Notes)                   HTML     24K 
25: R12         Medical Costs Payable (Notes)                       HTML     40K 
26: R13         Commercial Paper and Long-Term Debt (Notes)         HTML    205K 
27: R14         Shareholders' Equity (Notes)                        HTML     30K 
28: R15         Commitments and Contingencies (Notes)               HTML     30K 
29: R16         Segment Financial Information (Notes)               HTML    311K 
30: R17         Basis of Presentation Basis of Presentation         HTML     45K 
                (Policies)                                                       
31: R18         Investments Investments (Policies)                  HTML     23K 
32: R19         Investments (Tables)                                HTML    219K 
33: R20         Fair Value (Tables)                                 HTML    182K 
34: R21         Medical Costs Payable (Tables)                      HTML     40K 
35: R22         Commercial Paper and Long-Term Debt (Tables)        HTML    205K 
36: R23         Shareholders' Equity (Tables)                       HTML     28K 
37: R24         Segment Financial Information (Tables)              HTML    310K 
38: R25         Basis of Presentation Basis of Presentation, Uses   HTML     27K 
                of Estimates and Significant Accounting Policies                 
                (Details)                                                        
39: R26         Investments (Narrative) (Details)                   HTML     25K 
40: R27         Investments (Short-Term and Long-Term Investments)  HTML     84K 
                (Details)                                                        
41: R28         Investments (Amortized Cost and Fair Value of       HTML     92K 
                Available-for-Sale Debt Securities by Contractual                
                Maturity) (Details)                                              
42: R29         Investments (Fair Value of Available-For-Sale       HTML     62K 
                Investments with Gross Unrealized Losses by                      
                Investment Type and Length of Time That Individual               
                Securities Have Been in a Continuous Unrealized                  
                Loss Position) (Details)                                         
43: R30         Fair Value (Narrative) (Details)                    HTML     36K 
44: R31         Fair Value (Financial Assets and Liabilities        HTML     84K 
                Measured at Fair Value on a Recurring Basis)                     
                (Details)                                                        
45: R32         Fair Value (Financial Assets and Liabilities, Not   HTML     78K 
                Measured at Fair Value on a Recurring Basis)                     
                (Details)                                                        
46: R33         Other Current Receivables (Details)                 HTML     22K 
47: R34         Medical Costs Payable (Narrative) (Details)         HTML     20K 
48: R35         Medical Costs Payable Rollforward (Details)         HTML     42K 
49: R36         Commercial Paper and Long-Term Debt (Narrative)     HTML     69K 
                (Details)                                                        
50: R37         Commercial Paper and Long-Term Debt (Details)       HTML    163K 
51: R38         Commercial Paper and Long-Term Debt Subsequent      HTML     37K 
                Events (Details)                                                 
52: R39         Shareholders' Equity (Details)                      HTML     23K 
53: R40         Commitments and Contingencies (Details)             HTML     32K 
54: R41         Segment Financial Information (Narrative)           HTML     27K 
                (Details)                                                        
55: R42         Segment Financial Information (Details)             HTML     99K 
57: XML         IDEA XML File -- Filing Summary                      XML     97K 
56: EXCEL       IDEA Workbook of Financial Reports                  XLSX     65K 
 8: EX-101.INS  XBRL Instance -- unh-20170930                        XML   3.70M 
10: EX-101.CAL  XBRL Calculations -- unh-20170930_cal                XML    190K 
11: EX-101.DEF  XBRL Definitions -- unh-20170930_def                 XML    633K 
12: EX-101.LAB  XBRL Labels -- unh-20170930_lab                      XML   1.35M 
13: EX-101.PRE  XBRL Presentations -- unh-20170930_pre               XML    803K 
 9: EX-101.SCH  XBRL Schema -- unh-20170930                          XSD    126K 
58: ZIP         XBRL Zipped Folder -- 0000731766-17-000045-xbrl      Zip    217K

‘EX-101.SCH’ — XBRL Schema — unh-20170930

This Exhibit is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.uhc.com/20170930" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:unh="http://www.uhc.com/20170930" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">

<xsd:import namespace="http://fasb.org/us-gaap/2017-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd"/>

<xsd:import namespace="http://fasb.org/us-roles/2017-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2017/elts/us-roles-2017-01-31.xsd"/>

<xsd:import namespace="http://fasb.org/us-types/2017-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2017/elts/us-types-2017-01-31.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>

<xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>

<xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>

<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/currency/2017-01-31" schemaLocation="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/exch/2017-01-31" schemaLocation="http://xbrl.sec.gov/exch/2017/exch-2017-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd"/>

<xsd:annotation>

<xsd:appinfo>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20170930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20170930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20170930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20170930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>

<link:roleType id="BasisOfPresentationBasisOfPresentationPolicies" roleURI="http://www.uhc.com/role/BasisOfPresentationBasisOfPresentationPolicies">

<link:definition> 2217201 - Disclosure - Basis of Presentation Basis of Presentation (Policies) </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>